Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Zill, P; Engel, R; Hampel, H; Behrens, S; Burger, K; Padberg, F; Stubner, S; Moller, HJ; Ackenheil, M; Bondy, B
   Polymorphisms in the apolipoprotein E (APOE) gene in gerontopsychiatric patients
   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
   
   P. Zill et al., "Polymorphisms in the apolipoprotein E (APOE) gene in gerontopsychiatric patients", EUR ARCH PS, 251(1), 2001, pp. 24-28
2. Padberg, F; Juckel, G; Prassl, A; Zwanzger, P; Mavrogiorgou, P; Hegerl, U; Hampel, H; Moller, HJ
   Prefrontal cortex modulation of mood and emotionally induced facial expressions: A transcranial magnetic stimulation study
   JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
   
   F. Padberg et al., "Prefrontal cortex modulation of mood and emotionally induced facial expressions: A transcranial magnetic stimulation study", J NEUROP CL, 13(2), 2001, pp. 206-212
3. Lue, LF; Rydel, R; Brigham, EF; Yang, LB; Hampel, H; Murphy, GM; Brachova, L; Yan, SD; Walker, DG; Shen, Y; Rogers, J
   Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro
   GLIA
   
   L.F. Lue et al., "Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro", GLIA, 35(1), 2001, pp. 72-79
4. Itoh, N; Arai, H; Urakami, K; Ishiguro, K; Ohno, H; Hampel, H; Buerger, K; Wiltfang, J; Otto, M; Kretzschmar, H; Moeller, HJ; Imagawa, M; Kohno, H; Nakashima, K; Kuzuhara, S; Sasaki, H; Imahori, K
   Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease
   ANNALS OF NEUROLOGY
   
   N. Itoh et al., "Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease", ANN NEUROL, 50(2), 2001, pp. 150-156
5. Hampel, H; Buerger, K; Kohnken, R; Teipel, SJ; Zinkowski, R; Moeller, HJ; Rapoport, SI; Davies, P
   Tracking of Alzheimer's disease progression with cerebrospinal fluid tau protein phosphorylated at threonine 231
   ANNALS OF NEUROLOGY
   
   H. Hampel et al., "Tracking of Alzheimer's disease progression with cerebrospinal fluid tau protein phosphorylated at threonine 231", ANN NEUROL, 49(4), 2001, pp. 545-546
6. Padberg, F; Haase, CG; Feneberg, W; Schwarz, MJ; Hampel, H
   No association between anti-myelin oligodendrocyte glycoprotein antibodiesand serum/cerebrospinal fluid levels of the soluble interleukin-6 receptorcomplex in multiple sclerosis
   NEUROSCIENCE LETTERS
   
   F. Padberg et al., "No association between anti-myelin oligodendrocyte glycoprotein antibodiesand serum/cerebrospinal fluid levels of the soluble interleukin-6 receptorcomplex in multiple sclerosis", NEUROSCI L, 305(1), 2001, pp. 13-16
7. Zhou, XP; Hampel, H; Thiele, H; Gorlin, RJ; Hennekam, RCM; Parisi, M; Winter, RM; Eng, C
   Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes
   LANCET
   
   X.P. Zhou et al., "Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes", LANCET, 358(9277), 2001, pp. 210-211
8. Eng, C; Hampel, H; de la Chapelle, A
   Genetic testing for cancer predisposition
   ANNUAL REVIEW OF MEDICINE
   
   C. Eng et al., "Genetic testing for cancer predisposition", ANN R MED, 52, 2001, pp. 371-400
9. Du, Y; Dodel, R; Hampel, H; Buerger, K; Lin, S; Eastwood, B; Bales, K; Gao, F; Moeller, HJ; Oertel, W; Farlow, M; Paul, S
   Reduced levels of amyloid beta-peptide antibody in Alzheimer disease
   NEUROLOGY
   
   Y. Du et al., "Reduced levels of amyloid beta-peptide antibody in Alzheimer disease", NEUROLOGY, 57(5), 2001, pp. 801-805
10. Satzger, W; Hampel, H; Padberg, F; Burger, K; Nolde, T; Ingrassia, G; Engel, RR
    Practical application of the CERAD test battery in screening for neuropsychological dementia
    NERVENARZT
    
    W. Satzger et al., "Practical application of the CERAD test battery in screening for neuropsychological dementia", NERVENARZT, 72(3), 2001, pp. 196-203
11. Chadwick, RB; Pyatt, RE; Niemann, TH; Richards, SK; Johnson, CK; Stevens, MW; Meek, JE; Hampel, H; Prior, TW; de la Chapelle, A
    Hereditary and somatic DNA mismatch repair gene mutations in sporadic endometrial carcinoma
    JOURNAL OF MEDICAL GENETICS
    
    R.B. Chadwick et al., "Hereditary and somatic DNA mismatch repair gene mutations in sporadic endometrial carcinoma", J MED GENET, 38(7), 2001, pp. 461-466
12. Zhou, XP; Woodford-Richens, K; Lehtonen, R; Kurose, K; Aldred, M; Hampel, H; Launonen, V; Virta, S; Pilarski, R; Salovaara, R; Bodmer, WF; Conrad, BA; Dunlop, M; Hodgson, SV; Iwama, T; Jarvinen, H; Kellokumpu, I; Kim, JC; Leggett, B; Markie, D; Mecklin, JP; Neale, K; Phillips, R; Piris, J; Rozen, P; Houlston, RS; Aaltonen, LA; Tomlinson, IPM; Eng, C
    Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes
    AMERICAN JOURNAL OF HUMAN GENETICS
    
    X.P. Zhou et al., "Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes", AM J HU GEN, 69(4), 2001, pp. 704-711
13. Hampel, H; Bynum, GD; Zamora, E; El-Serag, HB
    Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis
    AMERICAN JOURNAL OF GASTROENTEROLOGY
    
    H. Hampel et al., "Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis", AM J GASTRO, 96(7), 2001, pp. 2206-2210
14. Hampel, H; Scheloske, M; Haslinger, A
    Physiology and biochemistry of the interleukin-6 receptor complex: Implications for CNS disorders and Alzheimer's disease
    NEUROINFLAMMATORY MECHANISMS IN ALZHEIMER'S DISEASE
    
    H. Hampel et al., "Physiology and biochemistry of the interleukin-6 receptor complex: Implications for CNS disorders and Alzheimer's disease", PROG INFLAM, 2001, pp. 121-143
15. Vanmechelen, E; Van Kerschaver, E; Blennow, K; De Deyn, PP; Galasko, D; Parnetti, L; Sindic, CJM; Arai, H; Riemenschneider, M; Hampel, H; Pottel, H; Valgaeren, A; Hulstaert, F; Vanderstichele, H
    CSF-phospho-tau (181P) as a promising marker for discriminating Alzheimer's disease from dementia with Lewy bodies
    ALZHEIMER'S DISEASE
    
    E. Vanmechelen et al., "CSF-phospho-tau (181P) as a promising marker for discriminating Alzheimer's disease from dementia with Lewy bodies", ALZHEIMER'S DISEASE, 2001, pp. 285-291
16. Auer, S; Hampel, H; Moller, HJ; Reisberg, B
    Translations of measurements and scales: Opportunities and diversities
    INTERNATIONAL PSYCHOGERIATRICS
    
    S. Auer et al., "Translations of measurements and scales: Opportunities and diversities", INT PSYCHOG, 12, 2000, pp. 391-394
17. Zhou, XP; Marsh, DJ; Hampel, H; Mulliken, JB; Gimm, O; Eng, C
    Germline and germline mosaic PTEN mutations associated with a Proteus-likesyndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis
    HUMAN MOLECULAR GENETICS
    
    X.P. Zhou et al., "Germline and germline mosaic PTEN mutations associated with a Proteus-likesyndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis", HUM MOL GEN, 9(5), 2000, pp. 765-768
18. Hofman, M; Seifritz, E; Krauchi, K; Hock, C; Hampel, H; Neugebauer, A; Muller-Spahn, F
    Alzheimer's disease, depression and normal ageing: Merit of simple psychomotor and visuospatial tasks
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    
    M. Hofman et al., "Alzheimer's disease, depression and normal ageing: Merit of simple psychomotor and visuospatial tasks", INT J GER P, 15(1), 2000, pp. 31-39
19. Zoghlache, MD; Burger, K; Schuck, S; Moller, HJ; Rapoport, SI; Allain, H; Hampel, H
    Multiconceptual therapy in Alzheimer's disease
    PRESSE MEDICALE
    
    M.D. Zoghlache et al., "Multiconceptual therapy in Alzheimer's disease", PRESSE MED, 29(21), 2000, pp. 1197-1201
20. Zill, P; Burger, K; Behrens, S; Hampel, H; Padberg, F; Boetsch, T; Moller, HJ; Ackenheil, M; Bondy, B
    Polymorphisms in the alpha-2 macroglobulin gene in psychogeriatric patients
    NEUROSCIENCE LETTERS
    
    P. Zill et al., "Polymorphisms in the alpha-2 macroglobulin gene in psychogeriatric patients", NEUROSCI L, 294(2), 2000, pp. 69-72
21. Kohnken, R; Buerger, K; Zinkowski, R; Miller, C; Kerkman, D; DeBernardis, J; Shen, JF; Moller, HJ; Davies, P; Hampel, H
    Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid ofAlzheimer's disease patients
    NEUROSCIENCE LETTERS
    
    R. Kohnken et al., "Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid ofAlzheimer's disease patients", NEUROSCI L, 287(3), 2000, pp. 187-190
22. Zill, P; Padberg, F; de Jonge, S; Hampel, H; Burger, K; Stubner, S; Boetsch, T; Moller, HJ; Ackenheil, M; Bondy, B
    Serotonin transporter (5-HTT) gene polymorphism in psychogeriatric patients
    NEUROSCIENCE LETTERS
    
    P. Zill et al., "Serotonin transporter (5-HTT) gene polymorphism in psychogeriatric patients", NEUROSCI L, 284(1-2), 2000, pp. 113-115
23. Akiyama, H; Barger, S; Barnum, S; Bradt, B; Bauer, J; Cole, GM; Cooper, NR; Eikelenboom, P; Emmerling, M; Fiebich, BL; Finch, CE; Frautschy, S; Griffin, WST; Hampel, H; Hull, M; Landreth, G; Lue, LF; Mrak, R; Mackenzie, IR; McGeer, PL; O'Banion, MK; Pachter, J; Pasinetti, G; Plata-Salaman, C; Rogers, J; Rydel, R; Shen, Y; Streit, W; Strohmeyer, R; Tooyoma, I; Van Muiswinkel, FL; Veerhuis, R; Walker, D; Webster, S; Wegrzyniak, B; Wenk, G; Wyss-Coray, T
    Inflammation and Alzheimer's disease
    NEUROBIOLOGY OF AGING
    
    H. Akiyama et al., "Inflammation and Alzheimer's disease", NEUROBIOL A, 21(3), 2000, pp. 383-421
24. Gallinat, J; Boetsch, T; Padberg, F; Hampel, H; Herrmann, WM; Hegerl, U
    Is the EEC helpful in diagnosing and monitoring lithium intoxication? A case report and review of the literature
    PHARMACOPSYCHIATRY
    
    J. Gallinat et al., "Is the EEC helpful in diagnosing and monitoring lithium intoxication? A case report and review of the literature", PHARMACOPS, 33(5), 2000, pp. 169-173
25. Pietrini, P; Alexander, GE; Furey, ML; Hampel, H; Guazzelli, M
    The neurometabolic landscape of cognitive decline: in vivo studies with positron emission tomography in Alzheimer's disease
    INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY
    
    P. Pietrini et al., "The neurometabolic landscape of cognitive decline: in vivo studies with positron emission tomography in Alzheimer's disease", INT J PSYCP, 37(1), 2000, pp. 87-98
26. Kahle, P; Teipel, SJ; Hampel, H; Murphy, GM
    Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF - Reply
    NEUROLOGY
    
    P. Kahle et al., "Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF - Reply", NEUROLOGY, 55(7), 2000, pp. 1068-1069
27. Kahle, PJ; Jakowec, M; Teipel, SJ; Hampel, H; Petzinger, GM; Di Monte, DA; Silverberg, GD; Moller, HJ; Yesavage, JA; Tinklenberg, JR; Shooter, EM; Murphy, GM
    Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF
    NEUROLOGY
    
    P.J. Kahle et al., "Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF", NEUROLOGY, 54(7), 2000, pp. 1498-1504
28. Westman, J; Hampel, H; Bradley, T
    Efficacy of a touchscreen computer based family cancer history questionnaire and subsequent cancer risk assessment
    JOURNAL OF MEDICAL GENETICS
    
    J. Westman et al., "Efficacy of a touchscreen computer based family cancer history questionnaire and subsequent cancer risk assessment", J MED GENET, 37(5), 2000, pp. 354-360
29. Hampel, H; Peltomaki, P
    Hereditary colorectal cancer: risk assessment and management
    CLINICAL GENETICS
    
    H. Hampel e P. Peltomaki, "Hereditary colorectal cancer: risk assessment and management", CLIN GENET, 58(2), 2000, pp. 89-97
30. Zhou, XP; Gimm, O; Hampel, H; Niemann, T; Walker, MJ; Eng, C
    Epigenetic PTEN silencing in malignant melanomas without PTEN mutation
    AMERICAN JOURNAL OF PATHOLOGY
    
    X.P. Zhou et al., "Epigenetic PTEN silencing in malignant melanomas without PTEN mutation", AM J PATH, 157(4), 2000, pp. 1123-1128
31. Ehrhardt, T; Plattner, A; Padberg, F; Moller, HJ; Hampel, H
    Behavioral treatment of a patient with early-stage Alzheimer's disease
    VERHALTENSTHERAPIE
    
    T. Ehrhardt et al., "Behavioral treatment of a patient with early-stage Alzheimer's disease", VERHALTENST, 9(3), 1999, pp. 154-161
32. Hampel, H; Kotter, HU; Padberg, F; Korschenhausen, DA; Moller, HJ
    Oligoclonal bands and blood-cerebrospinal-fluid barrier dysfunction in a subset of patients with Alzheimer disease: Comparison with vascular dementia, major depression, and multiple sclerosis
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS
    
    H. Hampel et al., "Oligoclonal bands and blood-cerebrospinal-fluid barrier dysfunction in a subset of patients with Alzheimer disease: Comparison with vascular dementia, major depression, and multiple sclerosis", ALZ DIS A D, 13(1), 1999, pp. 9-19
33. Buch, KBN; Padberg, F; Nolde, T; Teipel, SJ; Stubner, S; Haslinger, A; Schwarz, MJ; Sunderland, T; Arai, H; Rapoport, SI; Moller, HJ; Hampel, H
    Cerebrospinal fluid tau protein shows a better discrimination in young old(< 70 years) than in old old patients with Alzheimer's disease compared with controls
    NEUROSCIENCE LETTERS
    
    K.B.N. Buch et al., "Cerebrospinal fluid tau protein shows a better discrimination in young old(< 70 years) than in old old patients with Alzheimer's disease compared with controls", NEUROSCI L, 277(1), 1999, pp. 21-24
34. Stubner, S; Schon, T; Padberg, F; Teipel, SJ; Schwarz, MJ; Haslinger, A; Buch, K; Dukoff, R; Lasser, R; Muller, N; Sunderland, T; Rapoport, SI; Moller, HJ; Hampel, H
    Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinalfluid of geriatric patients with major depression: no alteration of soluble gp130
    NEUROSCIENCE LETTERS
    
    S. Stubner et al., "Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinalfluid of geriatric patients with major depression: no alteration of soluble gp130", NEUROSCI L, 259(3), 1999, pp. 145-148
35. Moller, HJ; Hampel, H; Hegerl, U; Schmitt, W; Walter, K
    Double-blind, randomized, placebo-controlled clinical trial on the efficacy and tolerability of a physostigmine patch in patients with senile dementia of the Alzheimer type
    PHARMACOPSYCHIATRY
    
    H.J. Moller et al., "Double-blind, randomized, placebo-controlled clinical trial on the efficacy and tolerability of a physostigmine patch in patients with senile dementia of the Alzheimer type", PHARMACOPS, 32(3), 1999, pp. 99-106
36. Padberg, F; Feneberg, W; Schmidt, S; Schwarz, MJ; Korschenhausen, D; Greenberg, BD; Nolde, T; Muller, N; Trapmann, H; Konig, N; Moller, HJ; Hampel, H
    CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis
    JOURNAL OF NEUROIMMUNOLOGY
    
    F. Padberg et al., "CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis", J NEUROIMM, 99(2), 1999, pp. 218-223
37. Padberg, F; Zwanzger, P; Thoma, H; Kathmann, N; Haag, C; Greenberg, BD; Hampel, H; Moller, HJ
    Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMSI
    PSYCHIATRY RESEARCH
    
    F. Padberg et al., "Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMSI", PSYCHIAT R, 88(3), 1999, pp. 163-171
38. Hampel, H; Teipel, SJ; Padberg, F; Haslinger, A; Riemenschneider, M; Schwarz, MJ; Kotter, HU; Scheloske, M; Buch, K; Stubner, S; Dukoff, R; Lasser, R; Muller, N; Sunderland, T; Rapoport, SI; Moller, HJ
    Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease
    BRAIN RESEARCH
    
    H. Hampel et al., "Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease", BRAIN RES, 823(1-2), 1999, pp. 104-112
39. Teipel, SJ; Hampel, H; Pietrini, P; Alexander, GE; Horwitz, B; Daley, E; Moller, HJ; Schapiro, MB; Rapoport, SI
    Region-specific corpus callosum atrophy correlates with the regional pattern of cortical glucose metabolism in Alzheimer disease
    ARCHIVES OF NEUROLOGY
    
    S.J. Teipel et al., "Region-specific corpus callosum atrophy correlates with the regional pattern of cortical glucose metabolism in Alzheimer disease", ARCH NEUROL, 56(4), 1999, pp. 467-473
40. Hampel, H; Padberg, F; Buch, K; Unger, J; Stubner, S; Moller, HJ
    Diagnosis and treatment of Alzheimer-type dementia
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    
    H. Hampel et al., "Diagnosis and treatment of Alzheimer-type dementia", DEUT MED WO, 124(5), 1999, pp. 124-129
41. RUJESCU D; RASP G; GAESE F; GRUNZE H; PADBERG F; HEGERL U; MOLLER HJ; HAMPEL H; STAMM S
    SPLICING FACTORS IN CULTURED OLFACTORY NEUROEPITHELIAL CELLS FROM BIOPSIES IN AD
    European journal of neuroscience
    
    D. Rujescu et al., "SPLICING FACTORS IN CULTURED OLFACTORY NEUROEPITHELIAL CELLS FROM BIOPSIES IN AD", European journal of neuroscience, 10, 1998, pp. 3214-3214
42. EHRHARDT T; HAMPEL H; HEGERL U; MOLLER HJ
    THE BEHAVIORAL COMPETENCE TRAINING (VERHA LTENSTHERAPEUTISCHES-KOMPETENZTRAINING) VKT - A SPECIFIC INTERVENTION FOR PATIENTS WITH EARLY-STAGE ALZHEIMERS-DISEASE
    Zeitschrift fur Gerontologie
    
    T. Ehrhardt et al., "THE BEHAVIORAL COMPETENCE TRAINING (VERHA LTENSTHERAPEUTISCHES-KOMPETENZTRAINING) VKT - A SPECIFIC INTERVENTION FOR PATIENTS WITH EARLY-STAGE ALZHEIMERS-DISEASE", Zeitschrift fur Gerontologie, 31(2), 1998, pp. 112-119
43. LEE PS; PIEHLER HR; ADAMS BL; JARVIS G; HAMPEL H; ROLLETT AD
    INFLUENCE OF SURFACE TEXTURE ON ORANGE PEEL IN ALUMINUM
    Journal of materials processing technology
    
    P.S. Lee et al., "INFLUENCE OF SURFACE TEXTURE ON ORANGE PEEL IN ALUMINUM", Journal of materials processing technology, 80-1, 1998, pp. 315-319
44. HAMPEL H; BERGER C; BUCH K; MOLLER HJ
    A REVIEW OF THE REVERSIBLE MAO-A INHIBITOR MOCLOBEMIDE IN GERIATRIC-PATIENTS
    Human psychopharmacology
    
    H. Hampel et al., "A REVIEW OF THE REVERSIBLE MAO-A INHIBITOR MOCLOBEMIDE IN GERIATRIC-PATIENTS", Human psychopharmacology, 13(1), 1998, pp. 43-51
45. FRANK TS; MANLEY SA; OLOPADE OI; CUMMINGS S; GARBER JE; BERNHARDT B; ANTMAN K; RUSSO D; WOOD ME; MULLINEAU L; ISAACS C; PESHKIN B; BUYS S; VENNE V; ROWLEY PT; LOADER S; OFFIT K; ROBSON M; HAMPEL H; BRENER D; WINER EP; CLARK S; WEBER B; STRONG LC; RIEGER P; MCCLURE M; WARD BE; SHATTUCKEIDENS D; OLIPHANT A; SKOLNICK MH; THOMAS A
    SEQUENCE-ANALYSIS OF BRCA1 AND BRCA2 - CORRELATION OF MUTATIONS WITH FAMILY HISTORY AND OVARIAN-CANCER RISK
    Journal of clinical oncology
    
    T.S. Frank et al., "SEQUENCE-ANALYSIS OF BRCA1 AND BRCA2 - CORRELATION OF MUTATIONS WITH FAMILY HISTORY AND OVARIAN-CANCER RISK", Journal of clinical oncology, 16(7), 1998, pp. 2417-2425
46. TEIPEL SJ; HAMPEL H; ALEXANDER GE; SCHAPIRO MB; HORWITZ B; TEICHBERG D; DALEY E; HIPPIUS H; MOLLER HJ; RAPOPORT SI
    DISSOCIATION BETWEEN CORPUS-CALLOSUM ATROPHY AND WHITE-MATTER PATHOLOGY IN ALZHEIMERS-DISEASE
    Neurology
    
    S.J. Teipel et al., "DISSOCIATION BETWEEN CORPUS-CALLOSUM ATROPHY AND WHITE-MATTER PATHOLOGY IN ALZHEIMERS-DISEASE", Neurology, 51(5), 1998, pp. 1381-1385
47. PADBERG F; STUBNER S; BUCH K; HEGERL U; HAMPEL H
    PISA SYNDROME DURING TREATMENT WITH SERTINDOLE
    British Journal of Psychiatry
    
    F. Padberg et al., "PISA SYNDROME DURING TREATMENT WITH SERTINDOLE", British Journal of Psychiatry, 173, 1998, pp. 351-352
48. HAMPEL H; SUNDERLAND T; KOTTER HU; SCHNEIDER C; TEIPEL SJ; PADBERG F; DUKOFF R; LEVY J; MOLLER HJ
    DECREASED SOLUBLE INTERLEUKIN-6 RECEPTOR IN CEREBROSPINAL-FLUID OF PATIENTS WITH ALZHEIMERS-DISEASE
    Brain research
    
    H. Hampel et al., "DECREASED SOLUBLE INTERLEUKIN-6 RECEPTOR IN CEREBROSPINAL-FLUID OF PATIENTS WITH ALZHEIMERS-DISEASE", Brain research, 780(2), 1998, pp. 356-359
49. HAMPEL H; TEIPEL SJ; ALEXANDER GE; HORWITZ B; TEICHBERG D; SCHAPIRO MB; RAPOPORT SI
    CORPUS-CALLOSUM ATROPHY IS A POSSIBLE INDICATOR OF REGION-TYPE-SPECIFIC AND CELL-TYPE-SPECIFIC NEURONAL DEGENERATION IN ALZHEIMER-DISEASE -A MAGNETIC-RESONANCE-IMAGING ANALYSIS
    Archives of neurology
    
    H. Hampel et al., "CORPUS-CALLOSUM ATROPHY IS A POSSIBLE INDICATOR OF REGION-TYPE-SPECIFIC AND CELL-TYPE-SPECIFIC NEURONAL DEGENERATION IN ALZHEIMER-DISEASE -A MAGNETIC-RESONANCE-IMAGING ANALYSIS", Archives of neurology, 55(2), 1998, pp. 193-198
50. LAKEN SJ; PETERSEN GM; GRUBER SB; ODDOUX C; OSTRER H; GIARDIELLO FM; HAMILTON SR; HAMPEL H; MARKOWITZ A; KLIMSTRA D; JHANWAR S; WINAWER S; OFFIT K; LUCE MC; KINZLER KW; VOGELSTEIN B
    FAMILIAL COLORECTAL-CANCER IN ASHKENAZIM DUE TO A HYPERMUTABLE TRACT IN APC
    Nature genetics
    
    S.J. Laken et al., "FAMILIAL COLORECTAL-CANCER IN ASHKENAZIM DUE TO A HYPERMUTABLE TRACT IN APC", Nature genetics, 17(1), 1997, pp. 79-83
51. MENTIS MJ; ALEXANDER GE; GRADY CL; HORWITZ B; KRASUSKI J; PIETRINI P; STRASSBURGER T; HAMPEL H; SCHAPIRO MB; RAPOPORT SI
    FREQUENCY VARIATION OF A PATTERN-FLASH VISUAL STIMULUS DURING PET DIFFERENTIALLY ACTIVATES BRAIN FROM STRIATE THROUGH FRONTAL-CORTEX
    NeuroImage
    
    M.J. Mentis et al., "FREQUENCY VARIATION OF A PATTERN-FLASH VISUAL STIMULUS DURING PET DIFFERENTIALLY ACTIVATES BRAIN FROM STRIATE THROUGH FRONTAL-CORTEX", NeuroImage, 5(2), 1997, pp. 116-128
52. HAMPEL H; KOTTER HU; MOLLER HJ
    BLOOD-CEREBROSPINAL FLUID BARRIER DYSFUNCTION FOR HIGH-MOLECULAR-WEIGHT PROTEINS IN ALZHEIMER-DISEASE AND MAJOR DEPRESSION - INDICATION FORDISEASE SUBSETS
    Alzheimer disease and associated disorders
    
    H. Hampel et al., "BLOOD-CEREBROSPINAL FLUID BARRIER DYSFUNCTION FOR HIGH-MOLECULAR-WEIGHT PROTEINS IN ALZHEIMER-DISEASE AND MAJOR DEPRESSION - INDICATION FORDISEASE SUBSETS", Alzheimer disease and associated disorders, 11(2), 1997, pp. 78-87
53. HAMPEL H; SCHOEN D; SCHWARZ MJ; KOTTER HU; SCHNEIDER C; SUNDERLAND T; DUKOFF R; LEVY J; PADBERG F; STUBNER S; BUCH K; MULLER N; MOLLER HJ
    INTERLEUKIN-6 IS NOT ALTERED IN CEREBROSPINAL-FLUID OF FIRST-DEGREE RELATIVES AND PATIENTS WITH ALZHEIMERS-DISEASE
    Neuroscience letters
    
    H. Hampel et al., "INTERLEUKIN-6 IS NOT ALTERED IN CEREBROSPINAL-FLUID OF FIRST-DEGREE RELATIVES AND PATIENTS WITH ALZHEIMERS-DISEASE", Neuroscience letters, 228(3), 1997, pp. 143-146
54. SHATTUCKEIDENS D; OLIPHANT A; MCCLURE M; MCBRIDE C; GUPTE J; RUBANO T; PRUSS D; TAVTIGIAN SV; TENG DHF; ADEY N; STAEBELL M; GUMPPER K; LUNDSTROM R; HULICK M; KELLY M; HOLMEN J; LINGENFELTER B; MANLEY S; FUJIMURA F; LUCE M; WARD B; CANNONALBRIGHT L; STEELE L; OFFIT K; GILEWSKI T; NORTON L; BROWN K; SCHULZ C; HAMPEL H; SCHLUGER A; GIULOTTO E; ZOLI W; RAVAIOLI A; NEVANLINNA H; PYRHONEN S; ROWLEY P; LOADER S; OSBORNE MP; DALY M; TEPLER I; WEINSTEIN PL; SCALIA JL; MICHAELSON R; SCOTT RJ; RADICE P; PIEROTTI MA; GARBER JE; ISAACS C; PESHKIN B; LIPPMAN ME; DOSIK MH; CALIGO MA; GREENSTEIN RM; PILARSKI R; WEBER B; BURGEMEISTER R; FRANK TS; SKOLNICK MH; THOMAS A
    BRCA-1 SEQUENCE-ANALYSIS IN WOMEN AT HIGH-RISK FOR SUSCEPTIBILITY MUTATIONS - RISK FACTOR-ANALYSIS AND IMPLICATIONS FOR GENETIC TESTING
    JAMA, the journal of the American Medical Association
    
    D. Shattuckeidens et al., "BRCA-1 SEQUENCE-ANALYSIS IN WOMEN AT HIGH-RISK FOR SUSCEPTIBILITY MUTATIONS - RISK FACTOR-ANALYSIS AND IMPLICATIONS FOR GENETIC TESTING", JAMA, the journal of the American Medical Association, 278(15), 1997, pp. 1242-1250
55. HAMPEL H; TEIPEL SJ; KOTTER HU; HORWITZ B; PFLUGER T; MAGER T; MOLLER HJ; MULLERSPAHN F
    STRUCTURAL MAGNETIC-RESONANCE-IMAGING IN DIAGNOSIS AND RESEARCH OF ALZHEIMERS-DISEASE
    Nervenarzt
    
    H. Hampel et al., "STRUCTURAL MAGNETIC-RESONANCE-IMAGING IN DIAGNOSIS AND RESEARCH OF ALZHEIMERS-DISEASE", Nervenarzt, 68(5), 1997, pp. 365-378
56. HAAS B; ROBSON M; RAJAN P; ROSEN PP; BORGEN P; BROWN K; HAMPEL H; SCHULZ C; GILEWSKI T; NORTON L; OFFIT K
    BRCA-ASSOCIATED BREAST-CANCER - ABSENCE OF A CHARACTERISTIC IMMUNOPHENOTYPE
    American journal of human genetics
    
    B. Haas et al., "BRCA-ASSOCIATED BREAST-CANCER - ABSENCE OF A CHARACTERISTIC IMMUNOPHENOTYPE", American journal of human genetics, 61(4), 1997, pp. 360-360
57. NEUHAUSEN S; GILEWSKI T; NORTON L; TRAN T; MCGUIRE P; SWENSEN J; HAMPEL H; BORGEN P; BROWN K; SKOLNICK M; SHATTUCKEIDENS D; JHANWAR S; GOLDGAR D; OFFIT K
    RECURRENT BRCA2 6174DELT MUTATIONS IN ASHKENAZI JEWISH WOMEN AFFECTEDBY BREAST-CANCER
    Nature genetics
    
    S. Neuhausen et al., "RECURRENT BRCA2 6174DELT MUTATIONS IN ASHKENAZI JEWISH WOMEN AFFECTEDBY BREAST-CANCER", Nature genetics, 13(1), 1996, pp. 126-128
58. HAMPEL H; BERGER C; MULLERSPAHN F
    PSYCHODRUG-INDUCED AND EDTA ASSOCIATED THROMBOCYTOPENIA - IMPORTANT FACTORS IN THE DIFFERENTIAL-DIAGNOSIS OF LOW PLATELET COUNTS
    European psychiatry
    
    H. Hampel et al., "PSYCHODRUG-INDUCED AND EDTA ASSOCIATED THROMBOCYTOPENIA - IMPORTANT FACTORS IN THE DIFFERENTIAL-DIAGNOSIS OF LOW PLATELET COUNTS", European psychiatry, 11(8), 1996, pp. 416-418
59. HAMPEL H; SCHNEIDER C; HOCK C; MULLERSPAHN F; ACKENHEIL M
    CNS DEMYELINATION IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) - POSSIBLE CAUSE OF A DEMENTIA SYNDROME
    European psychiatry
    
    H. Hampel et al., "CNS DEMYELINATION IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) - POSSIBLE CAUSE OF A DEMENTIA SYNDROME", European psychiatry, 11(1), 1996, pp. 46-49
60. HAMPEL H; BERGER C; MOLLER HJ; MULLERSPAHN F
    ORAL ANTICOAGULATION UNDER THE INFLUENCE OF REVERSIBLE AND IRREVERSIBLE MAO INHIBITORS
    Human psychopharmacology
    
    H. Hampel et al., "ORAL ANTICOAGULATION UNDER THE INFLUENCE OF REVERSIBLE AND IRREVERSIBLE MAO INHIBITORS", Human psychopharmacology, 11(1), 1996, pp. 69-70
61. MEHLS O; HAFFNER D; WUHL E; TONSHOFF B; SCHAEFER F; HEINRICH U; BITTNER K; EHRICH JHH; FILLER G; GELLERMANN J; HAMPEL H; BACHMANN H; RUDER H; BONZEL KE; SCHELLER B; DIPPELL J; ZIMMERHACKL LB; KREUDER J; RASCHER W; MULLERWIEFEL DE; MISSELWITZ J; RONNEFARTH B; QUERFELD U; EICHSTADT H; GREINER C; KELLER E; WEBER HP; HEISE HR; WIEMANN D; BEETZ R; SASSE D; SOERGEL M; PISTOR K; ZLOTKOWSKI A; KLARE B; EIFE R; KUWERTZBROKING E; WIGGER M; MIX M; EICHER O
    GROWTH-HORMONE AS A NEW TREATMENT MODALITY FOR SHORT CHILDREN WITH CHRONIC-RENAL-FAILURE
    Hormone research
    
    O. Mehls et al., "GROWTH-HORMONE AS A NEW TREATMENT MODALITY FOR SHORT CHILDREN WITH CHRONIC-RENAL-FAILURE", Hormone research, 46(4-5), 1996, pp. 230-235
62. HAMPEL H; BERGER C; MULLER N
    A CASE OF GANSERS STATE PRESENTING AS A DEMENTIA SYNDROME
    Psychopathology
    
    H. Hampel et al., "A CASE OF GANSERS STATE PRESENTING AS A DEMENTIA SYNDROME", Psychopathology, 29(4), 1996, pp. 236-241
63. HAMPEL H; BERGER C; KUSS HJ; MULLERSPAHN F
    UNSTABLE ANTICOAGULATION IN THE COURSE OF AMITRIPTYLINE TREATMENT
    Pharmacopsychiatry
    
    H. Hampel et al., "UNSTABLE ANTICOAGULATION IN THE COURSE OF AMITRIPTYLINE TREATMENT", Pharmacopsychiatry, 29(1), 1996, pp. 33-37
64. MARKOWITZ AJ; ZAUBER A; BREITE I; GERDES H; SHIKE M; KURTZ RC; GUILLEM J; COHEN A; OFFIT K; TAYLOR F; KUHN T; BLOCH A; HAMPEL H; WU D; LIN KH; AGRAWAL N; JHANWAR S; WINAWER SJ
    COLORECTAL-CANCER PREVENTION PROGRAM (CCPP)
    Gastroenterology
    
    A.J. Markowitz et al., "COLORECTAL-CANCER PREVENTION PROGRAM (CCPP)", Gastroenterology, 110(4), 1996, pp. 554-554
65. HAMPEL H; BERGER C; MULLERSPAHN F
    MODIFIED ORAL ANTICOAGULANT POTENCY IN AN AMITRIPTYLINE-TREATED PATIENT
    Acta haematologica
    
    H. Hampel et al., "MODIFIED ORAL ANTICOAGULANT POTENCY IN AN AMITRIPTYLINE-TREATED PATIENT", Acta haematologica, 96(3), 1996, pp. 178-180
66. HAMPEL H; MULLERSPAHN F; BERGER C; HABERL A; ACKENHEIL M; HOCK C
    EVIDENCE OF BLOOD CEREBROSPINAL FLUID-BARRIER IMPAIRMENT IN A SUBGROUP OF PATIENTS WITH DEMENTIA OF THE ALZHEIMER-TYPE AND MAJOR DEPRESSION- A POSSIBLE INDICATOR FOR IMMUNOACTIVATION
    Dementia
    
    H. Hampel et al., "EVIDENCE OF BLOOD CEREBROSPINAL FLUID-BARRIER IMPAIRMENT IN A SUBGROUP OF PATIENTS WITH DEMENTIA OF THE ALZHEIMER-TYPE AND MAJOR DEPRESSION- A POSSIBLE INDICATOR FOR IMMUNOACTIVATION", Dementia, 6(6), 1995, pp. 348-354
67. HAMPEL H; PUTZ A; MULLER N
    MAJOR DEPRESSION FOLLOWING MYIASIS WITH HYPEREOSINOPHILIC SYNDROME
    The Journal of clinical psychiatry
    
    H. Hampel et al., "MAJOR DEPRESSION FOLLOWING MYIASIS WITH HYPEREOSINOPHILIC SYNDROME", The Journal of clinical psychiatry, 56(7), 1995, pp. 333-334
68. HAMPEL H; BERGER C; KEILER BD; MULLERSPAHN F
    UNSTABLE ORAL ANTICOAGULATION IN A PATIEN T TREATED WITH TRICYCLIC ANTIDEPRESSANT
    Herz, Kreislauf
    
    H. Hampel et al., "UNSTABLE ORAL ANTICOAGULATION IN A PATIEN T TREATED WITH TRICYCLIC ANTIDEPRESSANT", Herz, Kreislauf, 27(5), 1995, pp. 170-171